Aracil-Bolaños, Ignacio
Sampedro, Frederic
Marín-Lahoz, Juan
Horta-Barba, Andrea
Martínez-Horta, Saül
Gónzalez-de-Echávarri, José María
Pérez-Pérez, Jesús
Bejr-Kasem, Helena
Pascual-Sedano, Berta
Botí, Mariángeles
Campolongo, Antonia
Izquierdo, Cristina
Gironell, Alexandre
Gómez-Ansón, Beatriz
Kulisevsky, Jaime
Pagonabarraga, Javier
Funding for this research was provided by:
Fundació la Marató de TV3 (20142910)
Instituto de Salud Carlos III (FIS Grant PI14/02058)
Article History
Accepted: 15 August 2021
First Online: 22 September 2021
Declarations
: All patients provided written informed consent according to the Declaration of Helsinki. The study was approved by the Ethics Comitee for Clinical Research at the Hospital de la Santa Creu i Sant Pau, Barcelona.
: The work of Dr. Aracil is supported by the Spanish Neurological Society via the Movement Disorders Study Group Grant, and is employed by Hospital de la Santa Creu i Sant Pau. The work of Dr. Bejr-Kasem is supported by Instituto de Salud Carlos III, Spain and has served on advisory or speakers’ boards, and received honoraria from Zambon. Dr. Javier Pagonabarraga has served on advisory or speakers’ boards, and received honoraria from UCB, Zambon, AbbVie, Italfarmaco, Allergan, Ipsen and Bial, and received grants from CIBERNED & FIS PI14/02058) (Spanish Government grants) and Fundació La Marató de TV3 20,142,910. Dr. Kulisevsky has received research grants from CIBERNED & FIS PI15/00962 (Spanish Government grants), and Fundació La Marató de TV3 20,142,410, and consulting fees or speaker honoraria from Zambon, Roche, Abbvie, Bial, UCB and Teva. Jesus Perez-Perez is employed as a Joan Rodes researcher (Spanish Government contract) and received grants from FIS (PI17/001885). Saul Martinez-Horta, Mariángeles Boti, Andrea Horta-Barba, Frederic Sampedro, Alexandre Gironell, Antonia Campolongo, Cristina Izquierdo, José María Gónzalez-de-Echávarri and Juan Marín-Lahoz are employed by Hospital de la Santa Creu i Sant Pau and report no other conflict of interest or funding.